Literature DB >> 20368673

A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks.

Robert J Snyder1, Matthew Cardinal, Damien M Dauphinée, James Stavosky.   

Abstract

Percent area reduction (PAR) after 4 weeks of diabetic foot ulcer (DFU) treatment has been suggested as a clinical monitoring parameter to distinguish DFUs that will heal within 12 weeks from those that will not despite standard wound care. The purpose of this post-hoc analysis of control DFU treatment outcomes from two published, randomized, controlled studies was to assess the relationship between PAR during early standard wound care and ulcer closure by week 12. The proportion of DFUs healed after 12 weeks was 57% (39 out of 69; 95% confidence interval [CI], 44% to 68%) in study A and 52% (38 out of 73; 95% CI, 40% to 64%) in study B for wounds with > or = 50% PAR by week 4 and 5% (three out of 64; 95% CI, 1% to 13%) and 2% (one out of 44; 95% CI, 0.1% to 12%), respectively, for DFUs with < 50% PAR at week 4. Regardless of baseline size category, DFUs with < 50% PAR at 4 weeks were less likely to heal by 12 weeks than DFUs with > or = 50% PAR (P < or = 0.001). Using pooled data, PAR at weeks 1 to 3 also varied between ulcers that did and did not heal after 12 weeks but sensitivity and specificity was highest on week 4. These findings confirm that percent reduction in wound size is an early predictor of treatment outcome and that protocols of care should be re-evaluated if > or = 50% PAR is not achieved. Studies to assess DFU healing before and after 4 weeks of standard wound care are needed to further refine these guidelines of care.

Entities:  

Mesh:

Year:  2010        PMID: 20368673

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  19 in total

1.  Differentiating diabetic foot ulcers that are unlikely to heal by 12 weeks following achieving 50% percent area reduction at 4 weeks.

Authors:  Robert A Warriner; Robert J Snyder; Matthew H Cardinal
Journal:  Int Wound J       Date:  2011-09-23       Impact factor: 3.315

Review 2.  Commentary on the conversion to an advanced standard of care for the treatment of diabetic foot ulcers and other chronic wounds.

Authors:  Donald E Mrdjenovich
Journal:  J Am Col Certif Wound Spec       Date:  2010-09-21

Review 3.  Quality Randomized Clinical Trials of Topical Diabetic Foot Ulcer Healing Agents.

Authors:  Laura L Bolton
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-03-01       Impact factor: 4.730

4.  Breath-Hold Paradigm to Assess Variations in Oxygen Flow in Diabetic Foot Ulcers Using a Noncontact Near-Infrared Optical Scanner.

Authors:  Kevin Leiva; Jagadeesh Mahadevan; Kacie Kaile; Richard Schutzman; Edwin Robledo; Sivakumar Narayanan; Varalakshmi Muthukrishnan; Viswanathan Mohan; Wensong Wu; Anuradha Godavarty
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-07-25       Impact factor: 4.730

Review 5.  On the Cutting Edge: Wound Care for the Endovascular Specialist.

Authors:  Brandon Olivieri; Timothy E Yates; Sofia Vianna; Omosalewa Adenikinju; Robert E Beasley; Jon Houseworth
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

6.  Point-of-Care Wound Blotting with Alcian Blue Grading versus Fluorescence Imaging for Biofilm Detection and Predicting 90-Day Healing Outcomes.

Authors:  Yu-Feng Wu; Yu-Chen Lin; Hung-Wei Yang; Nai-Chen Cheng; Chao-Min Cheng
Journal:  Biomedicines       Date:  2022-05-22

Review 7.  Recent technological advances in the management of chronic wounds: A literature review.

Authors:  Benson G Ongarora
Journal:  Health Sci Rep       Date:  2022-05-19

8.  Correction of Hypoxia, a Critical Element for Wound Bed Preparation Guidelines: TIMEO2 Principle of Wound Bed Preparation.

Authors:  Jayesh B Shah
Journal:  J Am Col Certif Wound Spec       Date:  2011-10-09

9.  Outcomes and prognosis of diabetic foot ulcers treated by an interdisciplinary team in Canada.

Authors:  Jérôme Patry; André Tourigny; Marie-Philippe Mercier; Clermont E Dionne
Journal:  Int Wound J       Date:  2020-11-25       Impact factor: 3.315

10.  Granulation response and partial wound closure predict healing in clinical trials on advanced diabetes foot ulcers treated with recombinant human epidermal growth factor.

Authors:  Carmen M Valenzuela-Silva; Ángela D Tuero-Iglesias; Elizeth García-Iglesias; Odalys González-Díaz; Amaurys Del Río-Martín; Isis Belkis Yera Alos; José I Fernández-Montequín; Pedro A López-Saura
Journal:  Diabetes Care       Date:  2012-09-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.